Bridge Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 94.2%.

Top 13 shareholders own 20.42% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.45%	James Jungkue Lee	4,262,166	₩13.1b	33.9%	no data
4.09%	UTC Investment co.,Ltd	2,060,539	₩6.3b	0%	10.91%
3.02%	SV Investment Corporation	1,521,947	₩4.7b	0%	24.98%
2.05%	Haeseon Choi	1,034,408	₩3.2b	0%	no data
0.96%	PineBridge Investments LLC	485,229	₩1.5b	27.8%	0.01%
0.8%	Haeraz Investor Co.,Ltd.	403,237	₩1.2b	0%	no data
0.66%	Bridge Biotherapeutics, Inc.Employee Stock Ownership Association	331,728	₩1.0b	0%	no data
0.21%	Gauss Ventures Co., Ltd.	107,689	₩331.1m	0%	no data
0.082%	Jong-Jin Lim	41,400	₩127.3m	0%	no data
0.074%	B. Christopher Kim	37,555	₩115.5m	56.5%	no data
0.012%	Yonghui Lee	6,000	₩18.4m	0%	no data
0.0024%	Dimensional Fund Advisors LP	1,200	₩3.7m	0%	no data
0.0024%	Jason Jaesoon Kim	1,200	₩3.7m	0%	no data